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Abstract
Chronic wasting disease (CWD), the only known prion disease endemic in wildlife, is a persistent problem in both wild and
captive North American cervid populations. This disease continues to spread and cases are found in new areas each year.
Indirect transmission can occur via the environment and is thought to occur by the oral and/or intranasal route. Oral
transmission has been experimentally demonstrated and although intranasal transmission has been postulated, it has not
been tested in a natural host until recently. Prions have been shown to adsorb strongly to clay particles and upon oral
inoculation the prion/clay combination exhibits increased infectivity in rodent models. Deer and elk undoubtedly and
chronically inhale dust particles routinely while living in the landscape while foraging and rutting. We therefore
hypothesized that dust represents a viable vehicle for intranasal CWD prion exposure. To test this hypothesis, CWD-positive
brain homogenate was mixed with montmorillonite clay (Mte), lyophilized, pulverized and inoculated intranasally into
white-tailed deer once a week for 6 weeks. Deer were euthanized at 95, 105, 120 and 175 days post final inoculation and
tissues examined for CWD-associated prion proteins by immunohistochemistry. Our results demonstrate that CWD can be
efficiently transmitted utilizing Mte particles as a prion carrier and intranasal exposure.
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Introduction
Chronic wasting disease (CWD) is a naturally occurring
transmissible spongiform encephalopathy (TSE) of deer, elk and
moose that affects captive as well as wild populations. Currently,
15 states, 2 Canadian provinces and South Korea have reported
cases of CWD [1] with more being reported each year. Like all
prion diseases, conversion of a normal, host cellular prion protein
(PrPC) to a pathologic, misfolded form (PrPCWD) causes CWD.
This conversion process, according to the prion hypothesis, allows
aberrantly folded prions to replicate without a genome [2]. Death
inevitably occurs after onset of clinical disease. Direct animal-to-
animal [3] and indirect environmental [4] CWD transmission
have been shown to occur. Animal studies have demonstrated that
CWD-positive deer can disseminate CWD prions into the
environment via urine, feces and saliva [5–7]. Although the
concentration of prions in urine and feces is low, the total fecal and
urine output is high, with each deer depositing approximately
119 kg dry weight of feces/deer [8] and roughly 1000 L of urine
per deer into the environment annually. Elk excretion of prion is
likely greater as they are much larger animals. This ongoing,
progressive environmental contamination may be substantial in
areas with large cervid populations and a high incidence of CWD.
Once in the environment, prions can persist and transmit disease
years after removal of infected animals and indirect environmental
transmission in deer has been documented [4,9,10]. After
contaminated urine, feces or saliva have been deposited in the
environment on forage and soil, they become available for
ingestion and inhalation. Soil particles, particularly clay, tightly
adsorb prions [9,11,12] and soil is inadvertently ingested during
foraging with deer consuming an average of 16 g of soil per day
[13]. Soil is also intentionally ingested at mineral licks, which are
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utilized by deer, elk and moose (our unpublished observations).
Oral delivery of CWD-positive brain material into deer in the
laboratory resulted in effective transmission of the disease [14,15]
and soil-bound prions enhanced oral transmission in hamsters
[16]. In addition to oral ingestion of soil, deer and elk also stir up
and inhale dust during foraging, running and rutting behaviors
such as advertising, territorial, and hierarchical displays [17,18].
Male white-tailed deer mark territory by scraping patches of earth
and urinating on them. Other male and female deer then
encounter the scrape, smell the soil and perform the same
marking behavior [17]. Elk engage in several behaviors that can
aerosolize dry soil particles: dominance displays such as thrashing
the ground with their antlers as a visual performance for
challenging bulls and advertising displays for females such as
and pawing and scraping the ground with their antlers [18]. We
propose that inhalation of CWD-contaminated dust particles
during these behaviors is a likely route of exposure.
Intranasal (IN) infection has been validated in rodent models by
placing liquid inoculum into or in front of the nasal cavity [19–21].
Kincaid and Bartz discovered that although IN inoculated
hamsters had incubation times equivalent to orally inoculated
hamsters, the IN route was 10–100 times more efficient at
transmitting the disease [21]. This suggests that the IN route may
be an efficient route of transmission in natural situations. A recent
study utilizing aerosolized liquid inoculum demonstrated that
CWD can be transmitted via the nose in white-tailed deer [22]. In
the current study, CWD-positive brain homogenate was mixed
with montmorillonite clay (Mte), lyophilized, pulverized, and
atomized into the nasal cavity of white-tailed deer once a week for
six weeks, modeling a chronic environmental exposure. The deer
were euthanized at four time points and tissues were examined by
immunohistochemistry. We found that lyophilized CWD prion
particulate complexed to Mte was efficiently transmitted IN to




All procedures involving animals were performed to minimize
suffering and were approved by the Institutional Animal Care and
Use Committee at Colorado State University in accordance with
the USDA Animal Welfare Act Regulation. CFR, title 9, chapter
1, subchapter A, parts 1–4.
Fifteen white-tailed deer (Odocoileus virginianus) fawns of mixed
sex and PRNP genotype (codon 96) were purchased from a CWD-
free private deer facility (Northwoods White-tails, Missouri, US) in
June 2011 and transported to the USDA National Wildlife
Research Center (NWRC) in Fort Collins, CO. At the time of
transport fawns ranged from two to fourteen days of age. Fawns
were bottle-fed and were weaned by 16 weeks. One fawn was
euthanized at eight weeks of age due to an encephalitis of
unknown origin.
At twelve weeks of age 12 deer were transported to a Colorado
State University (CSU) BSL-2 facility for CWD-inoculation. The
remaining two deer served as controls and remained at the USDA
National Wildlife Research Center (NWRC) facility.
PRNP Genotyping
Blood was drawn from fawns upon arrival and sent to the
USDA Agricultural Research laboratory in Pullman, WA for
genetic analysis of the open reading frame of PRNP. All animals
were homozygous for the wild type amino acid at residue 95-
(glutamine Q). There were three genotypes present for codon 96: 5
were homozygous for the wild type allele encoding glycine (GG),
four were heterozygous for G and the alternative allele encoding
serine (GS) and five were homozygous SS. To assess any effects of
genotype on study results, deer from each genetic group were
distributed as evenly as possible among the euthanasia time point
groups.
Inoculum preparation
A 20% homogenate of white-tailed deer brain from experi-
mentally inoculated, CWD-terminal or CWD-negative deer was
generated in 0.56phosphate buffered saline (PBS) and glass beads
utilizing a Blue Bullet homogenizer (Next Advance, Averill Park,
NY) as previously described [23]. To verify the negative status of
the brain homogenate from the control animal, six rounds of serial
protein misfolding amplification (PMCA) were conducted and
samples visualized by western blot as previously described [23].
CWD status of the positive brain homogenate was verified by
western blot. Individual inoculums were prepared by thoroughly
mixing 1 ml of the 20% brain homogenate (200 mg total brain)
and 250 mg of Mte clay (Sigma, St. Louis, MO) in a plastic weigh
boat. Brain/clay slurry was lyophilized at room temperature for
24 hours under a chemical fume hood. A razor blade was used to
scrape and grind the dried mixture back into a fine powder (Fig. 1).
The resulting powdered inoculum was drawn into a blunt plastic
transfer pipette, sealed with parafilm, and kept at 280uC until
needed. To determine the size of the Mte clay particles, a sample
was analyzed by the Colorado State University Soil laboratory
(Fort Collins, CO) utilizing the pipette method [24].
Inoculum titer
We quantified the infectivity of our CWD+ inoculum with the
cervid prion cell assay (CPCA) as described previously [25].
Briefly, a 10% brain homogenate was made from a 20% inoculum
sample with cold PBS lacking Mg2+ and Ca2+. Homogenate was
passed through 18-, 23-, 26- and 28-gauge needles 15 times each,
and stored at 280uC until used. A rabbit kidney epithelial (RK13)
cell line (ATCC, Manassas VA) engineered to express deer prion
protein, referred to as Deer5E9-S1, which is highly sensitive to the
infection with deer CWD prions (manuscript in preparation) was
utilized in this assay Twenty thousand cells per well were plated in
96-well plates. One day later, cells were exposed to three-fold
serial dilutions of deer CWD+ brain homogenate prepared in cell
culture medium, ranging from 1022 to 1025, in a volume of 100 ml
Figure 1. Expulsion of the lypholized CWD/Mte inoculum from
a transfer pipette illustrating the ultrafine texture of the
inoculum.
doi:10.1371/journal.pone.0062455.g001
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per well. Cells that were not exposed to CWD prions served as a
background control.
Cells were passaged three times at four day intervals at 1:4 and
1:7 split ratios. When cells reached confluence at the third passage,
20,000 cells per well were filtered onto Multiscreen IP 96-well
0.45-mm filter plates (Elispot plates, Millipore, Billerica, MA).
Plates were dried at 50uC and cells were digested for 90 min at
37uC in 60 ml of lysis buffer containing 5 mg/ml proteinase K (PK)
then terminated with phenylmethanesulfonylfluoride (PMSF)
(2 mM). To expose the epitope of PrP27-30, cells were incubated
in 120 ml 3 M guanidinium thiocyanate in 10 mM Tris-HCl
(pH 8.0) for 10 min at room temperature then rinsed four times
with 160 ml PBS. For immunodetection, wells were filled with
120 ml of filtered 5% superblock (Pierce, Rockford, IL) and
incubated for one hr at room temperature. The solution was
removed by vacuum, and wells were incubated with 60 ml of 6H4
mAb, diluted 1: 5000 in TBST for one hr at RT or overnight at
4uC. Wells were rinsed four times with 160 ml of TBST then
incubated with 60 ml AP-a-Mouse IgG (Southern Biotechnology
Associates, Birmingham, AL), diluted 1: 5000 in TBST, after one
hr at RT, the wells were rinsed four times with 160 ml TBST,
followed by a final wash with PBS. Plates were allowed to dry
completely. Visualization was done by adding 60 ml of AP
conjugate substrate kit (Bio-Rad, Hercules, CA) at RT and rinsing
twice with 160 ml water and allowed to completely dry. Images
were scanned with a ImmunoSpot S6-V analyzer (Cellular
Technology Ltd, Shaker Heights, OH), and spot numbers were
determined using ImmunoSpot5 software (Cellular Technology
Ltd, Shaker Heights, OH). Statistical analyses were performed
using GraphPad Prism 5.0 for Mac OS X software. Prion titer was
calculated in spot-forming CPCA units per gram of wet brain
homogenate.
Inoculations
The deer were bottle-fed and hand-raised so they were easily
manually restrained for the intranasal inoculations. The plastic
transfer pipette containing the powdered inoculum was warmed to
room temperature, inserted approximately 3 cm into the left
nostril and inoculum puffed into the nasal cavity once a week for
six weeks, exposing each deer to a total of 1.2 g (wet weight) of
brain. Two mock-infected control deer were inoculated in the
same fashion using CWD-negative brain/clay inoculum. Three
deer were euthanized at each of three time points after the final
inoculation: 95, 105, 120 days post inoculation (DPI); and two
deer at 175 DPI. Because of the presence of genetic variation at
codon 96, a GG, GS and SS deer was placed in each of the four
time groups with the exception of the 105 DPI group, which
contained one GG and two SS genotypes. The control deer were
composed of one GG and one GS.
Inoculum tracking
Two tracking methods were employed to determine the
distribution of the CWD inoculum within nasal the cavity, both
grossly and microscopically, after inoculation. To grossly deter-
mine the distribution of the clay inoculum, 500 ml of green
fluorescent dye (GFD, Wizard Tattoo Ink, Chicago, IL) and
500 ml of deionized water were added to 250 mg of Mte clay and
mixed thoroughly. The mixture was prepared and inoculated IN
as described for brain homogenates. The ink was visible with both
ultraviolet and visible light. One control deer was manually
restrained and inoculated IN with GFD/Mte into the left nostril.
Forty-five minutes later the deer was euthanized and necropsy
conducted.
To track the uptake of the CWD/Mte material within the nasal
mucosa, a lyophilized, fluorescently-labeled CWD prion was
strategy employed. Purified deer CWD prion rods were isolated as
previously described [26] and conjugated to a Dylight 650
fluorescent tag using a Dylight antibody labeling kit (Thermo
Scientific Pierce, Waltham, NJ). Ten ml aliquots were each mixed
with 50 ml of deionized H2O then floated in the water bath of a
3000MP sonicator (Misonix, Farmingdale, NY) at 37uC and
sonicated for 30 sec at 70% maximum power. Sonicated,
fluorescent prions were mixed with an additional 450 ml of DI
H2O then with 250 mg of Mte clay in a weigh boat and
lyophilized. Prion/Mte dust was prepared and inoculated as the
brain inocula described above. The two deer from the final 175
DPI euthanasia time point were manually restrained and given the
prion/Mte inoculum in the left nostril at either 60 or 45 min prior
to euthanasia.
Deer were sedated with Xylazine (Lloyd Laboratories, Shenan-
doah, IA) then euthanized via intravenous injection of Beuthana-
sia-D (Schering-Plough Animal Health Corp., Union, NJ). Deer
were immediately transported to the Colorado State University
Veterinary Diagnostic Laboratory for a complete post mortem
examination.
At necropsy of the GFD/Mte tracer control deer, the nasal
cavity, throat, and head lymph nodes were examined for the
presence of GFD/Mte using a hand-held UV light source
(Spectroline, Westbury, NY). Nasal turbinates were serially
dissected and photographed. To detect microscopic-sized dyed
particles, a fluorescent microscope was used with a UV excitation
source and UV emission filter.
To visualize fluorescent prions, sections were counterstained
with 1 mg/mL of the Carbocyanin lipophilic tracer DiOC18 and
100 ng/mL DAPI for 20 minutes, then mounted using ProLong
Gold fluorescent mounting medium (Life Technologies, Madison,
WI). Five to twelve 5 mm thick, paraffin-embedded tissue sections
from nasal turbinates, retropharyngeal, submandibular and
parotid lymph nodes and tonsils were viewed and photographed
using an Olympus BX60 microscope (Center Valley, PA) equipped
with a cooled charge-coupled diode camera.
Immunohistochemistry
Retropharyngeal, submandibular, parotid, pre-scapular, pre-
femoral, mesenteric, and illiocecalcolic junction lymph nodes as
well as tonsils, Peyer’s patches, rectum, brain, and nasal tissues
(cribriform plate, and ethmoid turbinates, two sections from each)
were collected from the deer at necropsy and placed in 10%
neutral buffered formalin for one week. The nasal tissues were
then placed in 10% formic acid for three to five days for
decalcification, trimmed, and embedded in paraffin blocks. Other
tissues were trimmed and two to four sections of each were placed
in plastic cassettes and allowed to fix for an additional two days.
Slides were prepared as previously described for visualization and
evaluation [27]. Briefly, 5 mm tissue slices were mounted on
positively charged glass slides (Fisher Scientific, Houston, TX),
antigen retrieval with formic acid and hydrated autoclaving was
performed and F99/97.6.1 antibody was employed to detect
PrPCWD, a biomarker for CWD, followed by incubation with
alkaline phosphatase-conjugated anti-mouse IgG secondary anti-
body and visualized using an automated immnuostainer and an
alkaline phosphatase red kit (Ventana, Tucson). Slides were
counterstained with hematoxylin for four minutes at 37uC. Positive
and negative control slides containing lymphoid tissues and brain
were stained with each run. PrPCWD was visualized as granular red
staining showing protease-resistant deposits within lymphoid
Intranasal CWD Dust Inoculation in Deer
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follicles. All follicles were counted for each section present on each
slide, totaling between 1600–3069 follicles for each deer.
Results
Chronic wasting disease infection
The CWD status of the negative inoculum was verified by
PMCA and the positive by western blot analysis (data not shown)
prior to inoculation. Control brain inoculum remained negative
after six 24 hr rounds of PMCA amplification and western blot
visualization. Positive brain inoculum was positive on western blot
visualization. The deer CWD prion infectivity titer was deter-
mined by CPCA using a highly sensitive Deer 5E9-S1 cell line
(Fig. 2). The prion titers of the inoculum and a Tg(CerPrP-
M132)1536+/2 mouse-passaged CWD prion isolate 012-09442
were calculated as 106.1 and 106.6 cervid prion cell units per gram
of brain homogenate, (CPCA units/g), respectively. The results of
the titer assay revealed that the CWD prion inoculum titer was
approximately three times lower than that of a transgenic mouse
strain commonly used to generate disease in a mouse bioassay
(Fig. 2). All deer were healthy upon inoculation, however, shortly
after inoculation an SS deer in the 175 DPI group developed a
chronic GI infection that required long-term antibiotic treatment.
As a result this deer was excluded from the study.
We observed no clinical signs characteristic of CWD and no
detectable PrPCWD by IHC in the obex, thalamus, hypothalamus,
basal ganglia, olfactory bulb, or hippocampus of the brain in any
of the deer at any of the time points. We next investigated
subclinical infection by searching for PrPCWD in lymph nodes that
drain or are proximal to the nasal cavity; retropharyngeal,
submandibular, parotid, and palatine tonsil, as well as distal
lymph nodes, pre-scapular, pre-femoral, mesenteric, Peyer’s
patches and the recto-anal mucosa associated lymphoid tissue
(RAMALT). PrPCWD was not detected in either of the two mock-
infected control deer (0/2 at 175 DPI), but was detected in lymph
nodes of 10/11 of the CWD-inoculated deer by IHC (Table 1) as
early as 94 DPI. The number of CWD-positive follicles was not
significantly different at later time points (Fig. 3).
Figure 2. Quantification of deer CWD prion by the cervid prion
cell assay. A. Representative wells of an ELISPOT plate showing spots
given by triplicate deer 5E9-S1cells exposed to 3-fold serial dilutions of
CWD+ inoculate brain homogenate, deer CWD (upper) and Tg(CerPrP-
M132)1536+/2-passaged CWD prion isolate 012-09442 (lower), the
concentration of brain homogenates (left to right) are: 1022, 1022.5,
1022.9, 1023.4, 1023.9, 1024.4 and 1024.9. The wells at right are
uninfected Deer5E9-S1 cells. B. Responsiveness of Deer5E9-S1 cells to
the CWD+ inoculum and Tg(CerPrP-M132)1536+/2 mouse -passaged
CWD prion isolate 012-09442 were between 1022 and 1025. The cells
were infected with serial 1:3 dilutions of homogenates of CWD+
inoculum and subjected to the CPCA. In each case, the mean is derived
from experiments performed in triplicate, with error bars indicating the
standard errors of the means (SEM).
doi:10.1371/journal.pone.0062455.g002
Figure 3. Lymphoid Involvement at each of the 4 time points.
No significant difference was detected in the number of affected
follicles between the groups (ANOVA, p= 0. 86).
doi:10.1371/journal.pone.0062455.g003
Table 1. Detection of CWD in lymphoid follicles.
Codon 96 DPI Number of CWD+ follicles % of affected
genotype total follicles follicles
GG 175 0/2547 0%
GS 175 0/2900 0%
GS 95 663/2141 31%
GG 95 1376/1972 70%
SS 95 66/2939 2%
GG 105 828/1635 51%
SS 105 0/2338 0%
SS 105 20/3069 ,1%
GG 120 1751/2396 73%
GS 120 155/1763 9%
SS 120 168/2061 8%
GG 175 467/2790 17%
GS 175 471/1790 26%
Between 1600 and 3069 lymphoid follicles from head LNs, tonsils, pre-scapular
and femoral LNs, Peyer’s patches, mesenteric LN, gut LNs and rectum were
evaluated in each deer for the presence of CWD by IHC. Percentage of total
follicles IHC-positive for CWD ranged between 0-.70%, depending on
genotype. (*Control mock-infected deer).
doi:10.1371/journal.pone.0062455.t001
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Influence of genotype
Upon genotypic analysis, it was discovered that although all
deer were homozygous at codon 95 (QQ), all three genotypes
(GG, GS, and SS) were represented at codon 96. We therefore
sampled deer from each genotype at each time point. We found
that the genotype at codon 96 affected PrPCWD temporal
distribution and proportion of PrPCWD positive follicles within
the lymphoid system (Fig. 4). Overall, the deer with GG genotype
had a much wider PrPCWD distribution in the body and a higher
percentage of CWD-positive follicles in the retropharyngeal,
submandibular, parotid, pre-scapular, pre-femoral, and mesenter-
ic lymph nodes, palatine tonsils, Peyer’s patches, ileocecocolic
junction, and rectum. The number of CWD+ immunoreactive
follicles in the retropharyngeal, submandibular, parotid, palatine
tonsils, illiocecalcolic junction, and rectum were significantly
greater (Student’s one-tailed T-test p =,0.05) in the GG animals
as compared to SS deer. Follicle number in the palatine tonsils and
the rectum were significantly greater (Student’s one-tailed T-test
p =,0.05) than in GS deer (Fig. 4). Deer having the GS genotype
had fewer positive follicles and a more limited distribution with
positive follicles detected in the retropharyngeal, submandibular,
and parotid lymph nodes, palatine tonsils and Peyer’s patches
(Fig. 4). We found the most limited distribution and lowest number
of positive follicles in the deer with the SS genotype, with PrPCWD
detected only in the retropharyngeal, submandibuliar, and parotid
lymph nodes (Fig. 4). Genotype also had an influence on the
intensity of immunoreactivity within the affected lymph nodes,
with GG having the greatest number of stained granules, followed
by GS then SS (Fig. 5).
Inoculum tracking
To determine if the deposition of the initial inocula could
influence later replication sites and to understand the deposition
and initial contact/entry sites for prions and the Mte within the
nasal cavity, we sought to track the location of inocula
immediately after exposure. We first puffed GFD/Mte dust
(Fig. 1) into the nasal cavity and searched for it 45 min later.
Figure 4. Prnp genotype affects PrPCWD distribution and proportion of PrPCWD positive follicles in the lympoid system. The GG
genotype had a wider PrPCWD distribution than GS and SS. *Tissue CWD % was significantly less than the GG genotype. ¤ Tissue CWD % was
significantly less than the GS genotype. (Students one tailed T-test, p#0.05).
doi:10.1371/journal.pone.0062455.g004
Figure 5. PrPCWD immunolabeling in the retropharyngeal and
submandibular lymph nodes at 2006magnification, mAb F99/
97.6.1 and alkaline phosphatase detection.
doi:10.1371/journal.pone.0062455.g005
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The Mte is not readily visualized without the presence of the GFD.
Upon gross examination, we saw a small amount of GFD/Mte
under visible light and a significant amount under UV light on the
nasal mucosa of the nasal passages and to a lesser extent in the
nasopharanx (Fig. 6a). A few small spots were seen on the ethmoid
turbinates (Fig. 6b). Microscopic examination revealed GFD/Mte
on the mucus and surface epithelial cells of the nasal cavity (Fig. 6
c, d, e). We next puffed highly-enriched fluorescent prions
adsorbed to Mte into the nasal cavity and searched for them
microscopically based on the location of GFD/Mte. We found
fluorescently tagged prion rods in both animals after 45 and
60 min on and within the olfactory epithelium (OE, Fig. 7A), as
well as associated with nerve fibers (NF, Fig. 7b) and serous cells of
the Bowman’s glands (BG) in the lamina propria (LP) after 60 min
(Fig. 7D–G).
We detected no prions associated with blood or lymphatic
vessels in the lamina propria, or in any of the lymph nodes
Figure 6. Visualization of GFD/Mte particles. 6A. Longitudinal cut
of a deer head without GFD/Mte under a blacklight. Inset- dissected
nasal turbinates. 6B. Longitudinal cut of a deer head inoculated with
GFD/Mte under a black light with visible GFD/Mte deposition. Insets-
dissected nasal turbinates 6C. Ethmoid nasal turbinates under a
blacklight. Arrows and circles indicate small particles of GFD/Mte. 6D.
Mounted nasal turbinate with 1006 magnification showing GFD/Mte
particles associated with the nasal mucosa under normal light and with
a ultraviolet filter. OE-Olfactory epithelium, NC-Nasal Cavity. Arrows
indicate GFD/Mte (6E).
doi:10.1371/journal.pone.0062455.g006
Figure 7. Tracking lyophilized prion inocula in the nasal cavity
of deer. Highly enriched, fluorescently labeled prions were mixed with
Mte, lyophilized, pulverized and puffed into the nasal cavity. (A) After
45 minutes, florescent prion aggregates (red) can be seen on (white
arrowheads) and within the olfactory epithelium (OE) of the nasal
turbinates. Tissue sections are counterstained with DiOC18 fluorescent
membrane dye (green) and the nuclear stain DAPI (blue). A small
proportion of prions can be seen near serous cells of the Bowman’s
glands (BG) in the lamina propria. (B) By 60 min, significant amount of
prions were found in the lamina propria, with some aggregates
(arrowhead) associated with nerve fibers (NF) emanating from the OE.
(C) We detected no red signal from negative control sections from
mock-inoculated deer. (D–G) Higher magnification of a Bowman’s gland
stained with DAPI (D), DiOC18 (E) and decorated with prions (F) that
appear to localize on serous cells (G). NB, nerve bundle; scale bar,
20 mm.
doi:10.1371/journal.pone.0062455.g007
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examined, including the retropharyngeal, submandibular and
parotid lymph nodes, and palatine tonsils at these very early time
points.
Discussion
Indirect environmental CWD transmission has been demon-
strated and several infectious tissues and excreta have been
identified that could contaminate forage, soil and water
[5,6,7][28]. We also know that prions can adsorb to soil and its
components and remain infectious [16]. However, we know little
about how prions are re-introduced into hosts from the
environment. Here we model natural prion exposure to dry,
prion-adsorbed Mte particles that mimics natural, repeated IN
dust exposure at a volume significantly lower (1.2 g) than those
used in previous oral inoculation studies (5 and 10 g respectively)
[14,15]. We failed to detect PrPCWD in the brain as late as 175
days after IN PrPCWD dust exposure. All brain regions analyzed
were negative, demonstrating that although PrPCWD staining
could be detected in the lymph nodes of the head in all genotypes
and in more distal nodes in the GG genotype, observable PrPCWD
accumulation had not yet progressed to the brain.
The olfactory bulb was of particular interest in this study. There
are millions of olfactory sensory neurons (OSN) present in the
nasal mucosa that connect directly to the olfactory bulb [29,30].
Diseases such as polio, rabies and herpes simplex 1 infection [31–
33] and toxicants such as aflatoxin B [34] are able to take
advantage of this direct anterograde connection to infect the brain.
It has been suggested that infectious prions may utilize this same
route to enter the brain, as PrPRES deposition has been
documented in the olfactory bulb and nasal mucosa of terminally
ill, infected animals [35]. Additionally, both the OSNs and
olfactory bulb express PrPC in mice [30]. In this study, the
olfactory bulb, surrounding brain area and nasal mucosa did not
show deposition of PrPCWD by IHC, demonstrating that the
PrPCWD did not travel along these neurons to enter the brain by
175 DPI. Our results are in agreement with rodent studies that
show prion diseases are unable to make use of this direct
connection to the brain and that olfactory bulb and nasal mucosa
deposition occurs later in the disease, moving retrograde from the
brain to the olfactory bulb and then down the OSNs to the nasal
mucosa [20,35].
In contrast to the brain, we found substantial PrPCWD in the
lymph nodes and tonsils of the head (retropharyngeal, subman-
dibular and parotid lymph nodes) in all genotypes. The tonsil
findings are in agreement with those of a concurrent study using
aerosolization of liquid inoculum [22]. We detected PrPCWD in
mesenteric lymph nodes, Peyer’s patches and in lymphoid follicles
at the ileocecalcolic junction of the gut and rectum only in deer
expressing the GG PRNP genotype. Despite detecting original
inoculum deep within the nasal turbinates on OE and mucus-
secreting Bowman’s glands, IHC analysis of the nasal turbinates
did not reveal the presence of CWD prions later in infection.
Taken together, these data suggest that after IN exposure, CWD
infection begins in lymphoid tissues proximal to the nasal cavity
and later progresses to the brain.
Dust can be an environmentally realistic, chronic, low dose
mode of intranasal CWD exposure for deer and elk in the wild,
particularly in dry western states such as Colorado and Wyoming.
The size of dust particles is directly proportional to how far the
particles are able to travel into the respiratory tract, with particles
#1 mm able to travel into the deepest regions of the lung, 1–5 mm
into the bronchiolar region, 5 mm into the upper lung and
.10 mm caught in the nose and oral pharynx [36]. Analysis of the
Mte used in this study revealed that 2.5% of the particles were
10 mm, 5.3% were 5 mm, 36.4% were 2 mm and 55.8% were
#1 mm in accord with a previous study evaluating Mte particle
size [37]. Studies have shown that CWD can tightly adsorb to clay
particles, such as Mte, and cause disease after oral inoculation [9].
In this study, Mte was used as an effective dust carrier to transmit
CWD intranasally, however, further research needs to be
conducted to determine the binding relationship between the
CWD and the Mte. Mte is a widely distributed, biologically inert
clay, commonly called Fuller’s earth or bentonite. The large
surface area, negative charge and small size make Mte an effective
nanoparticle carrier for gene therapy DNA and chemotherapeutic
agents into the gut [37–39]. The binding of Mte to DNA and
drugs significantly enhances their mucoadhesion, cellular uptake
and efficacy within the gut; and confocal microscopy reveals that
Mte/drug particles are internalized into cells [37–39]. In a study
on gut particle uptake, 1 mm latex beads were detected in Peyer’s
patches and mesenteric lymph nodes six hrs after oral inoculation
[40]. Our gross examination of deer exposed to GFD/Mte tracer
demonstrated the extensive mucoadhesion of GFD/Mte inoculum
throughout the main nasal passage, associated nasal mucosa, and
mucus on peripheral nasal turbinate surfaces 45 min after
inoculation. It seems likely that the mucoadhesion increased
retention time of the inoculum and may have facilitated increased
CWD prion uptake. The initial experimental design of this study
included inoculating dried brain as well as brain/Mte, however,
drying the brain homogenate proved problematic. The texture of
the dried brain was extremely thick and sticky, prohibiting the
generation of a powder. As a result this component was
eliminated.
We detected fluorescent prions on and within the olfactory
epithelium and associated with nerve fibers and serous cells of the
Bowman’s glands in the lamina propria within one hr of exposure.
We hypothesize that PrPCWD traffics from the nasal mucosa to
draining lymph nodes via immune cells, or autonomously through
lymphatic drainage, or both [26].
Peyer’s patches in the gut and the nasal mucosa contain
dendritic cells (DC) and specialized membranous (M) cells [41–
43], which sample the lumen for antigens and present them to
regional lymph nodes [44–48]. Uptake of prions by DCs in the gut
has been implicated in prion disease transmission [49,50] with M
cells can trafficking prions across cellular and mucosal surfaces in
vitro and in vivo [51,52]. The presence and importance of DCs in
the nasal mucosa as first line of defense against inhaled microbes
and allergens, is well established [53–56]. DCs reside throughout
the olfactory epithelium at an airway density between 500 and
1000 cells/mm3 of nasal epithelium [57] and often sit atop, as well
as insert between tight junctions of, the Bowman’s glands [58]. We
propose that in this study DCs and M cells likely took up PrPCWD
from the olfactory epithelium and lamina propria and transported
them to regional draining lymph nodes. However, we cannot
eliminate paracellular or cell autonomous movement of prions, as
has previously been shown [26,59]. Inhalation of dust and other
particles has been shown to cause rhinitis that enhances cytokines
and increases the number of DCs in the nasal mucosa [55,60–62].
Influence of genotype
This study provided a unique opportunity to observe the effect
of the dimorphism at codon 96 on IN infection of deer with Mte-
adsorbed prion particulate. Several studies examining the preva-
lence of codon 96 polymorphisms have been done on wild
populations with the GG polymorphism being the most common
(72%), followed by GS (13–25%), and SS (3%) [63,64]. Wild GG
animals have a higher prevalence and shorter incubation period of
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CWD compared to GS and SS genotypes [65]. The distribution
and prevalence of CWD within the body of the SS and GS deer in
this study were significantly different from GG wild-type deer, with
GS and SS having CWD deposition predominantly in the head
lymph nodes. Lymph nodes are essential sites of CWD propaga-
tion in deer and elk [66]. We detected minor PrPCWD deposition
in the Peyer’s patches in one GS deer. These data suggest that GS
and SS deer have slower CWD progression in the peripheral
lymphoid tissues of the body, which may explain the delayed
progression of CWD observed in GS and SS mule deer by Miller
et. al [67].
The results of this study confirm that CWD can be successfully
transmitted IN as a lyophilized prion particulate adsorbed to Mte
and that genotype at codon 96 affects the lymphoid distribution of
CWD within the body. Additionally, two novel intranasal tracking
methods were employed that provided insight into CWD
translocation within the nasal cavity. The data collected in this
study may also shed light on why there is a higher prevalence of
CWD in males, as males participate in more behaviors that
generate dust. We propose chronic, long-term exposure to CWD
prions adsorbed to dust particles to be a natural CWD infection
route in addition to chronic oral and nasal contact exposure.
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